skip to main content
Resultados 1 2 3 4 next page
Mostrar Somente
Refinado por: assunto: Male remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours
Material Type:
Artigo
Adicionar ao Meu Espaço

Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours

Romer, A. ; Seiler, D. ; Marincek, N. ; Brunner, P. ; Koller, M. T. ; Ng, Q. K. T. ; Maecke, H. R. ; Müller-Brand, J. ; Rochlitz, C. ; Briel, M. ; Schindler, C. ; Walter, M. A.

European journal of nuclear medicine and molecular imaging, 2014-02, Vol.41 (2), p.214-222 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

2
Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study
Material Type:
Artigo
Adicionar ao Meu Espaço

Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study

Marincek, Nicolas ; Jörg, Ann-Catherine ; Brunner, Philippe ; Schindler, Christian ; Koller, Michael T ; Rochlitz, Christoph ; Müller-Brand, Jan ; Maecke, Helmut R ; Briel, Matthias ; Walter, Martin A

Journal of translational medicine, 2013-01, Vol.11 (1), p.17-17, Article 17 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

3
Cohort Study of Somatostatin-Based Radiopeptide Therapy With [90Y-DOTA]-TOC Versus [90Y-DOTA]-TOC Plus [177Lu-DOTA]-TOC in Neuroendocrine Cancers
Material Type:
Artigo
Adicionar ao Meu Espaço

Cohort Study of Somatostatin-Based Radiopeptide Therapy With [90Y-DOTA]-TOC Versus [90Y-DOTA]-TOC Plus [177Lu-DOTA]-TOC in Neuroendocrine Cancers

VILLARD, Linda ; ROMER, Anna ; BRIEL, Matthias ; WALTER, Martin A ; MARINCEK, Nicolas ; BRUNNER, Philippe ; KOLLER, Michael T ; SCHINDLER, Christian ; NG, Quinn KT ; MÄCKE, Helmut R ; MÜLLER-BRAND, Jan ; ROCHLITZ, Christoph

Journal of clinical oncology, 2012-04, Vol.30 (10), p.1100-1106 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

4
Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers
Material Type:
Artigo
Adicionar ao Meu Espaço

Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers

IMHOF, Anna ; BRUNNER, Philippe ; MARINCEK, Nicolas ; BRIEL, Matthias ; SCHINDLER, Christian ; RASCH, Helmut ; MÄCKE, Helmut R ; ROCHLITZ, Christoph ; MÜLLER-BRAND, Jan ; WALTER, Martin A

Journal of clinical oncology, 2011-06, Vol.29 (17), p.2416-2423 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

5
The German ACROSTUDY: past and present
Material Type:
Artigo
Adicionar ao Meu Espaço

The German ACROSTUDY: past and present

Buchfelder, M ; Schlaffer, S ; Droste, M ; Mann, K ; Saller, B ; Brübach, K ; Stalla, G K ; Strasburger, C J

European journal of endocrinology, 2009-11, Vol.161 (suppl_1), p.S3-S10 [Periódico revisado por pares]

England: BioScientifica

Texto completo disponível

6
Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study
Material Type:
Artigo
Adicionar ao Meu Espaço

Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study

Buchfelder, M ; Weigel, D ; Droste, M ; Mann, K ; Saller, B ; Brübach, K ; Stalla, G K ; Bidlingmaier, M ; Strasburger, C J

European journal of endocrinology, 2009-07, Vol.161 (1), p.27-35 [Periódico revisado por pares]

Bristol: BioScientifica

Texto completo disponível

7
[90Yttrium-DOTA]-TOC Response Is Associated With Survival Benefit in Iodine-Refractory Thyroid Cancer : Long-term Results of a Phase 2 Clinical Trial
Material Type:
Artigo
Adicionar ao Meu Espaço

[90Yttrium-DOTA]-TOC Response Is Associated With Survival Benefit in Iodine-Refractory Thyroid Cancer : Long-term Results of a Phase 2 Clinical Trial

ITEN, Fabienne ; MULLER, Beat ; SCHINDLER, Christian ; RASCH, Helmut ; ROCHLITZ, Christoph ; OERTLI, Daniel ; MAECKE, Helmut R ; MULLER-BRAND, Jan ; WALTER, Martin A

Cancer, 2009-05, Vol.115 (10), p.2052-2062 [Periódico revisado por pares]

Hoboken, NJ: Wiley-Blackwell

Texto completo disponível

8
Response to [90Yttrium-DOTA]-TOC Treatment is Associated with Long-term Survival Benefit in Metastasized Medullary Thyroid Cancer: A Phase II Clinical Trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Response to [90Yttrium-DOTA]-TOC Treatment is Associated with Long-term Survival Benefit in Metastasized Medullary Thyroid Cancer: A Phase II Clinical Trial

ITEN, Fabienne ; MÜLLER, Beat ; SCHINDLER, Christian ; ROCHLITZ, Christoph ; OERTLI, Daniel ; MÄCKE, Helmut R ; MÄLLER-BRAND, Jan ; WALTER, Martin A

Clinical cancer research, 2007-11, Vol.13 (22), p.6696-6702 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

9
An Open-Label, Noncomparative Phase II Trial to Evaluate the Efficacy and Safety of Docetaxel in Combination with Gefitinib in Patients with Hormone-Refractory Metastatic Prostate Cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

An Open-Label, Noncomparative Phase II Trial to Evaluate the Efficacy and Safety of Docetaxel in Combination with Gefitinib in Patients with Hormone-Refractory Metastatic Prostate Cancer

Salzberg, Marc ; Rochlitz, Christoph ; Morant, Rudolf ; Thalmann, George ; Pedrazzini, Augusto ; Roggero, Enrico ; Schönenberger, Astrid ; Knuth, Alexander ; Borner, Markus

Oncology research and treatment, 2007-07, Vol.30 (7), p.355-360 [Periódico revisado por pares]

Freiburg, Germany

Texto completo disponível

10
A case of post‐transplant lymphoproliferative disease presenting as CD20‐expressing, Epstein–Barr‐virus positive Hodgkin lymphoma
Material Type:
Artigo
Adicionar ao Meu Espaço

A case of post‐transplant lymphoproliferative disease presenting as CD20‐expressing, Epstein–Barr‐virus positive Hodgkin lymphoma

Stern, M. ; Herrmann, R. ; Rochlitz, C. ; Dirnhofer, S. ; Pless, M.

European journal of haematology, 2005-03, Vol.74 (3), p.267-270 [Periódico revisado por pares]

Oxford, UK: Munksgaard International Publishers

Texto completo disponível

Resultados 1 2 3 4 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (30)

Idioma 

  1. Inglês  (30)
  2. Japonês  (6)
  3. Alemão  (2)
  4. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.